Search the Site


test tubes

Shares of $MNKD continue to drop after CRL

publication date: Jan 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Last week MNKD recieved a CRL causing shares to drop about 25%.  This drop was not nearly as severe as I had expected, especially considering the long path ahead for MNKD.  Multiple clinical trials as well as possible dilution.  I was expecteing to see MNKD immediately trading in the $4 range, possibly as low as the mid $3's.  When shares only dipped into the $5's and bounced to the $6's I re-read the press releases and looked for a possible reason why share price was holding up so well- in fact they were stayin in the bottom range of the run-up.

Sorry this page is available to subscribers only. If you're not a subscriber why not join today?

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site including:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regualtory Catalyst Database (updated daily)
- Members Only Live Interactive Webinars 
- Weekly Watchlist
- Email / SMS (Text Message) Alerts of critical news
- A More Detailed FDA Calendar
- Direct Email Communication
- Affiliate Program

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.